Finance

Lists
ABNX:EPA
Abionyx Pharma SA
1,60 €
-1,11%
(-0,018) 1D
5-окт., 17:35:03 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABNX...
Open
1,64 €
High
1,70 €
Low
1,60 €
Mkt. cap
66,98 млн
Avg. vol.
162,85 миң
Volume
165,45 миң
52-wk high
5,21 €
52-wk low
1,60 €
EPS
-0,23 €
Shares outstanding
43,74 млн
No. of employees
49
Open
1,64 €
High
1,70 €
Low
1,60 €
Mkt. cap
66,98 млн
Avg. vol.
162,85 миң
Volume
165,45 миң
52-wk high
5,21 €
52-wk low
1,60 €
EPS
-0,23 €
Shares outstanding
43,74 млн
No. of employees
49
News stories
From web sources and news partners
About Abionyx Pharma SA
CEOCyrille Tupin
Employees49
Founded2005
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
1,06 млн
1,06 млн
972,00 миң
972,00 миң
Cost of goods sold
945,50 миң
945,50 миң
819,00 миң
819,00 миң
Cost of revenue
945,50 миң
945,50 миң
819,00 миң
819,00 миң
Research and development expenses
346,00 миң
346,00 миң
413,00 миң
413,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
938,00 миң
938,00 миң
1,35 млн
1,35 млн
Operating expense
1,28 млн
1,28 млн
1,76 млн
1,76 млн
Total operating expenses
2,22 млн
2,22 млн
2,58 млн
2,58 млн
Operating income
-1,16 млн
-1,16 млн
-1,60 млн
-1,60 млн
Other non operating income
11,00 миң
11,00 миң
-19,00 миң
-19,00 миң
EBT including unusual items
-1,15 млн
-1,15 млн
-1,62 млн
-1,62 млн
EBT excluding unusual items
-1,15 млн
-1,15 млн
-1,62 млн
-1,62 млн
Income tax expense
4,00 миң
4,00 миң
500,00
500,00
Effective tax rate
-0,35%
-0,35%
-0,03%
-0,03%
Other operating expenses
-5,00 миң
-5,00 миң
-5,00 миң
-5,00 миң
Net income
-1,15 млн
-1,15 млн
-1,62 млн
-1,62 млн
Net profit margin
-108,82%
-108,82%
-166,87%
-166,87%
Earnings per share
-
-
-
-
Interest and investment income
8,50 миң
8,50 миң
18,50 миң
18,50 миң
Interest expense
-26,50 миң
-26,50 миң
-16,00 миң
-16,00 миң
Net interest expenses
-18,00 миң
-18,00 миң
2,50 миң
2,50 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,13 млн
-1,13 млн
-1,58 млн
-1,58 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору